BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17653861)

  • 1. International Study of Health Care Organization and Financing of renal services in England and Wales.
    Nicholson T; Roderick P
    Int J Health Care Finance Econ; 2007 Dec; 7(4):283-99. PubMed ID: 17653861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The organization and financing of dialysis and kidney transplantation services in New Zealand.
    Ashton T; Marshall MR
    Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The organization and financing of end-stage renal disease in Spain.
    Luño J
    Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
    Wikström B; Fored M; Eichleay MA; Jacobson SH
    Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.
    Pontoriero G; Pozzoni P; Vecchio LD; Locatelli F
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):201-15. PubMed ID: 17641969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Study of Health Care Organization and Financing for end-stage renal disease in France.
    Durand-Zaleski I; Combe C; Lang P
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):171-83. PubMed ID: 17680359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International study of health care organization and financing: development of renal replacement therapy in Germany.
    Kleophas W; Reichel H
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):185-200. PubMed ID: 17701342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance and dialysis services.
    Lancet; 1990 Nov; 336(8724):1160-1. PubMed ID: 1978031
    [No Abstract]   [Full Text] [Related]  

  • 10. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.
    Manns BJ; Mendelssohn DC; Taub KJ
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):149-69. PubMed ID: 17641968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).
    Dor A; Pauly MV; Eichleay MA; Held PJ
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):73-111. PubMed ID: 17653860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The organization and financing of end-stage renal disease treatment in Japan.
    Fukuhara S; Yamazaki C; Hayashino Y; Higashi T; Eichleay MA; Akiba T; Akizawa T; Saito A; Port FK; Kurokawa K
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):217-31. PubMed ID: 17690980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The provision of renal replacement therapy for adults in England and Wales: recent trends and future directions.
    Roderick PJ; Ferris G; Feest TG
    QJM; 1998 Aug; 91(8):581-7. PubMed ID: 9893762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 15. The organization and funding of the treatment of end-stage renal disease in Australia.
    Harris A
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):113-32. PubMed ID: 17763938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-cost life prolongation: the National Kidney Dialysis and Kidney Transplantation Study.
    Gutman RA
    Ann Intern Med; 1988 Jun; 108(6):898-9. PubMed ID: 3285750
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of chronic kidney disease care in southeast Asia.
    Jha V
    Semin Nephrol; 2009 Sep; 29(5):487-96. PubMed ID: 19751894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and cost evaluation of hemodialysis in renal satellite units in England and Wales.
    Roderick P; Armitage A; Nicholson T; Mehta R; Gerard K; Mullee M; Drey N; Lamping D; Feest T; Greenwood R; Townsend J
    Am J Kidney Dis; 2004 Jul; 44(1):121-31. PubMed ID: 15211445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The databases: renal replacement therapy since 1989--the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA).
    Zoccali C; Kramer A; Jager K
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S18-22. PubMed ID: 19996000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.